Role of caspase 8 as a determinant in chemosensitivity of p53-mutated head and neck squamous cell carcinoma cell lines
We studied factors that control chemoresistanceto 6 head and neck squamous cell carcinomacell lines carrying p53 mutations. Cell lines werechosen, based on the presence of EGFR amplifications,the presence of H-ras mutations, and theabsence of either. WST-1 viability assays showedthat, in response to...
Gespeichert in:
Veröffentlicht in: | Journal of Medical and Dental Sciences 2006, Vol.53(1), pp.57-66 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 66 |
---|---|
container_issue | 1 |
container_start_page | 57 |
container_title | Journal of Medical and Dental Sciences |
container_volume | 53 |
creator | Kaneda, Yoshimasa Shimamoto, Hiroaki Matsumura, Kouji Arvind, Ramanathan Zhang, Shengliang Sakai, Eiki Omura, Ken Tsuchida, Nobuo |
description | We studied factors that control chemoresistanceto 6 head and neck squamous cell carcinomacell lines carrying p53 mutations. Cell lines werechosen, based on the presence of EGFR amplifications,the presence of H-ras mutations, and theabsence of either. WST-1 viability assays showedthat, in response to etoposide, Ca922 was mostsensitive, HOC313 most resistant, and HSC6 andthe others moderately sensitive. A similar tendencywas shown by further analyses with cisplatin, 5-fluorouracil,LY294002, and combined treatment withLY294002 and TNF-related apoptosis-inducing ligand(TRAIL). Although both Ca922 and HOC313 hadactivating mutations upstream of Akt signaling, theconstitutive phosphorylation of Akt at S473 wasobserved in chemosensitive Ca922, but not inchemoresistant HOC313, suggesting that constitutiveAkt phosphorylation was not the primarydeterminant for chemoresistance in these celllines. Further, by the combined treatment withLY294002 and TRAIL, apoptosis was induced inCa922 and HSC6 but not in HOC313. Interestingly,caspase 8 was not detected in HOC313, while itwas cleaved in the other 2 cell lines. Further, inCa922 and HSC6 but not in HOC313, caspase 8inhibitor restored loss of viability induced eitherwith LY294002 and TRAIL or even with etoposidealone. These findings suggest that caspase 8played an important role in chemoresistanceagainst genotoxic drugs. |
doi_str_mv | 10.11480/jmds.530108 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68005396</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68005396</sourcerecordid><originalsourceid>FETCH-LOGICAL-j481t-f8286a0dca8fa96a75a87444cd841bd64cc5b5201bd39a65024c7544c7b2f6223</originalsourceid><addsrcrecordid>eNo9kU1v1DAQhi0EoqvSG2fkE7cUf8c5VhUUpEpICM7WxJ6wXhJnGzuV-u_rKKWXmbHe149nPIR85Oyac2XZl9MU8rWWjDP7hhwEt7rpuBRvyYFLJRprObsgVznHngnJdct1955ccNMKwZU5kMdf84h0HqiHfIaM1FLIFGjAgssUE6RCY6L-iNOcMeVY4mMsT9uNs5bNtBYoGOgRIVBIgSb0_2h-WGGa10w9jmMlLz6meYL9OMaE-QN5N8CY8eolX5I_377-vv3e3P-8-3F7c9-clOWlGaywBljwYAfoDLQabKuU8sEq3gejvNe9FqzWsgOjmVC-1VVvezEYIeQl-bxzz8v8sGIubop5awMS1gadsYxp2Zlq_PRiXPsJgzsvcYLlyf3_qWq42w1VjR7GOW2DuNO8LqlO4HDsqoLZCcaM26iM12S3sq3B1HY6bkRXSTc76ZQL_MXXp2Ap0Y8VWVfqtHR8C_tqXzV_hMVhks_VFJlw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68005396</pqid></control><display><type>article</type><title>Role of caspase 8 as a determinant in chemosensitivity of p53-mutated head and neck squamous cell carcinoma cell lines</title><source>J-STAGE Free</source><source>MEDLINE</source><source>Freely Accessible Japanese Titles</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Kaneda, Yoshimasa ; Shimamoto, Hiroaki ; Matsumura, Kouji ; Arvind, Ramanathan ; Zhang, Shengliang ; Sakai, Eiki ; Omura, Ken ; Tsuchida, Nobuo</creator><creatorcontrib>Kaneda, Yoshimasa ; Shimamoto, Hiroaki ; Matsumura, Kouji ; Arvind, Ramanathan ; Zhang, Shengliang ; Sakai, Eiki ; Omura, Ken ; Tsuchida, Nobuo ; Tokyo Medical and Dental University ; Laboratory of Cell Analysis ; Central Research Institute ; Department of Molecular Cellular Oncology and Microbiology ; Oral and Maxillofacial Surgery ; Dokkyo University School of Medicine ; National Defense Medical College ; Department of Oral and Maxillofacial Surgery</creatorcontrib><description>We studied factors that control chemoresistanceto 6 head and neck squamous cell carcinomacell lines carrying p53 mutations. Cell lines werechosen, based on the presence of EGFR amplifications,the presence of H-ras mutations, and theabsence of either. WST-1 viability assays showedthat, in response to etoposide, Ca922 was mostsensitive, HOC313 most resistant, and HSC6 andthe others moderately sensitive. A similar tendencywas shown by further analyses with cisplatin, 5-fluorouracil,LY294002, and combined treatment withLY294002 and TNF-related apoptosis-inducing ligand(TRAIL). Although both Ca922 and HOC313 hadactivating mutations upstream of Akt signaling, theconstitutive phosphorylation of Akt at S473 wasobserved in chemosensitive Ca922, but not inchemoresistant HOC313, suggesting that constitutiveAkt phosphorylation was not the primarydeterminant for chemoresistance in these celllines. Further, by the combined treatment withLY294002 and TRAIL, apoptosis was induced inCa922 and HSC6 but not in HOC313. Interestingly,caspase 8 was not detected in HOC313, while itwas cleaved in the other 2 cell lines. Further, inCa922 and HSC6 but not in HOC313, caspase 8inhibitor restored loss of viability induced eitherwith LY294002 and TRAIL or even with etoposidealone. These findings suggest that caspase 8played an important role in chemoresistanceagainst genotoxic drugs.</description><identifier>ISSN: 1342-8810</identifier><identifier>EISSN: 2185-9132</identifier><identifier>DOI: 10.11480/jmds.530108</identifier><identifier>PMID: 16722146</identifier><language>eng</language><publisher>Japan: Tokyo Medical and Dental University (TMDU)</publisher><subject>Akt ; Antineoplastic Agents - pharmacology ; Apoptosis - drug effects ; Apoptosis Regulatory Proteins - pharmacology ; Carcinoma, Squamous Cell - enzymology ; Carcinoma, Squamous Cell - genetics ; Caspase 8 ; Caspases - physiology ; Cell Line, Tumor - drug effects ; Cell Line, Tumor - enzymology ; Chromones - pharmacology ; Cisplatin - pharmacology ; Dentistry ; Drug Resistance, Neoplasm - genetics ; Drug Resistance, Neoplasm - physiology ; etoposide ; Etoposide - pharmacology ; Fluorouracil - pharmacology ; Head and Neck Neoplasms - enzymology ; Head and Neck Neoplasms - genetics ; head and neck squamous cell carcinoma ; Humans ; Membrane Glycoproteins - pharmacology ; Morpholines - pharmacology ; Mutation ; Phosphorylation ; Proto-Oncogene Proteins c-akt - metabolism ; TNF-Related Apoptosis-Inducing Ligand ; TRAIL ; Tumor Necrosis Factor-alpha - pharmacology ; Tumor Suppressor Protein p53 - genetics</subject><ispartof>Journal of Medical and Dental Sciences, 2006, Vol.53(1), pp.57-66</ispartof><rights>2006 Tokyo Medical and Dental University (TMDU)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16722146$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kaneda, Yoshimasa</creatorcontrib><creatorcontrib>Shimamoto, Hiroaki</creatorcontrib><creatorcontrib>Matsumura, Kouji</creatorcontrib><creatorcontrib>Arvind, Ramanathan</creatorcontrib><creatorcontrib>Zhang, Shengliang</creatorcontrib><creatorcontrib>Sakai, Eiki</creatorcontrib><creatorcontrib>Omura, Ken</creatorcontrib><creatorcontrib>Tsuchida, Nobuo</creatorcontrib><creatorcontrib>Tokyo Medical and Dental University</creatorcontrib><creatorcontrib>Laboratory of Cell Analysis</creatorcontrib><creatorcontrib>Central Research Institute</creatorcontrib><creatorcontrib>Department of Molecular Cellular Oncology and Microbiology</creatorcontrib><creatorcontrib>Oral and Maxillofacial Surgery</creatorcontrib><creatorcontrib>Dokkyo University School of Medicine</creatorcontrib><creatorcontrib>National Defense Medical College</creatorcontrib><creatorcontrib>Department of Oral and Maxillofacial Surgery</creatorcontrib><title>Role of caspase 8 as a determinant in chemosensitivity of p53-mutated head and neck squamous cell carcinoma cell lines</title><title>Journal of Medical and Dental Sciences</title><addtitle>J. med. dent. sci.</addtitle><description>We studied factors that control chemoresistanceto 6 head and neck squamous cell carcinomacell lines carrying p53 mutations. Cell lines werechosen, based on the presence of EGFR amplifications,the presence of H-ras mutations, and theabsence of either. WST-1 viability assays showedthat, in response to etoposide, Ca922 was mostsensitive, HOC313 most resistant, and HSC6 andthe others moderately sensitive. A similar tendencywas shown by further analyses with cisplatin, 5-fluorouracil,LY294002, and combined treatment withLY294002 and TNF-related apoptosis-inducing ligand(TRAIL). Although both Ca922 and HOC313 hadactivating mutations upstream of Akt signaling, theconstitutive phosphorylation of Akt at S473 wasobserved in chemosensitive Ca922, but not inchemoresistant HOC313, suggesting that constitutiveAkt phosphorylation was not the primarydeterminant for chemoresistance in these celllines. Further, by the combined treatment withLY294002 and TRAIL, apoptosis was induced inCa922 and HSC6 but not in HOC313. Interestingly,caspase 8 was not detected in HOC313, while itwas cleaved in the other 2 cell lines. Further, inCa922 and HSC6 but not in HOC313, caspase 8inhibitor restored loss of viability induced eitherwith LY294002 and TRAIL or even with etoposidealone. These findings suggest that caspase 8played an important role in chemoresistanceagainst genotoxic drugs.</description><subject>Akt</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis Regulatory Proteins - pharmacology</subject><subject>Carcinoma, Squamous Cell - enzymology</subject><subject>Carcinoma, Squamous Cell - genetics</subject><subject>Caspase 8</subject><subject>Caspases - physiology</subject><subject>Cell Line, Tumor - drug effects</subject><subject>Cell Line, Tumor - enzymology</subject><subject>Chromones - pharmacology</subject><subject>Cisplatin - pharmacology</subject><subject>Dentistry</subject><subject>Drug Resistance, Neoplasm - genetics</subject><subject>Drug Resistance, Neoplasm - physiology</subject><subject>etoposide</subject><subject>Etoposide - pharmacology</subject><subject>Fluorouracil - pharmacology</subject><subject>Head and Neck Neoplasms - enzymology</subject><subject>Head and Neck Neoplasms - genetics</subject><subject>head and neck squamous cell carcinoma</subject><subject>Humans</subject><subject>Membrane Glycoproteins - pharmacology</subject><subject>Morpholines - pharmacology</subject><subject>Mutation</subject><subject>Phosphorylation</subject><subject>Proto-Oncogene Proteins c-akt - metabolism</subject><subject>TNF-Related Apoptosis-Inducing Ligand</subject><subject>TRAIL</subject><subject>Tumor Necrosis Factor-alpha - pharmacology</subject><subject>Tumor Suppressor Protein p53 - genetics</subject><issn>1342-8810</issn><issn>2185-9132</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kU1v1DAQhi0EoqvSG2fkE7cUf8c5VhUUpEpICM7WxJ6wXhJnGzuV-u_rKKWXmbHe149nPIR85Oyac2XZl9MU8rWWjDP7hhwEt7rpuBRvyYFLJRprObsgVznHngnJdct1955ccNMKwZU5kMdf84h0HqiHfIaM1FLIFGjAgssUE6RCY6L-iNOcMeVY4mMsT9uNs5bNtBYoGOgRIVBIgSb0_2h-WGGa10w9jmMlLz6meYL9OMaE-QN5N8CY8eolX5I_377-vv3e3P-8-3F7c9-clOWlGaywBljwYAfoDLQabKuU8sEq3gejvNe9FqzWsgOjmVC-1VVvezEYIeQl-bxzz8v8sGIubop5awMS1gadsYxp2Zlq_PRiXPsJgzsvcYLlyf3_qWq42w1VjR7GOW2DuNO8LqlO4HDsqoLZCcaM26iM12S3sq3B1HY6bkRXSTc76ZQL_MXXp2Ap0Y8VWVfqtHR8C_tqXzV_hMVhks_VFJlw</recordid><startdate>200603</startdate><enddate>200603</enddate><creator>Kaneda, Yoshimasa</creator><creator>Shimamoto, Hiroaki</creator><creator>Matsumura, Kouji</creator><creator>Arvind, Ramanathan</creator><creator>Zhang, Shengliang</creator><creator>Sakai, Eiki</creator><creator>Omura, Ken</creator><creator>Tsuchida, Nobuo</creator><general>Tokyo Medical and Dental University (TMDU)</general><general>Tokyo Medical and Dental University</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200603</creationdate><title>Role of caspase 8 as a determinant in chemosensitivity of p53-mutated head and neck squamous cell carcinoma cell lines</title><author>Kaneda, Yoshimasa ; Shimamoto, Hiroaki ; Matsumura, Kouji ; Arvind, Ramanathan ; Zhang, Shengliang ; Sakai, Eiki ; Omura, Ken ; Tsuchida, Nobuo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j481t-f8286a0dca8fa96a75a87444cd841bd64cc5b5201bd39a65024c7544c7b2f6223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Akt</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis Regulatory Proteins - pharmacology</topic><topic>Carcinoma, Squamous Cell - enzymology</topic><topic>Carcinoma, Squamous Cell - genetics</topic><topic>Caspase 8</topic><topic>Caspases - physiology</topic><topic>Cell Line, Tumor - drug effects</topic><topic>Cell Line, Tumor - enzymology</topic><topic>Chromones - pharmacology</topic><topic>Cisplatin - pharmacology</topic><topic>Dentistry</topic><topic>Drug Resistance, Neoplasm - genetics</topic><topic>Drug Resistance, Neoplasm - physiology</topic><topic>etoposide</topic><topic>Etoposide - pharmacology</topic><topic>Fluorouracil - pharmacology</topic><topic>Head and Neck Neoplasms - enzymology</topic><topic>Head and Neck Neoplasms - genetics</topic><topic>head and neck squamous cell carcinoma</topic><topic>Humans</topic><topic>Membrane Glycoproteins - pharmacology</topic><topic>Morpholines - pharmacology</topic><topic>Mutation</topic><topic>Phosphorylation</topic><topic>Proto-Oncogene Proteins c-akt - metabolism</topic><topic>TNF-Related Apoptosis-Inducing Ligand</topic><topic>TRAIL</topic><topic>Tumor Necrosis Factor-alpha - pharmacology</topic><topic>Tumor Suppressor Protein p53 - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kaneda, Yoshimasa</creatorcontrib><creatorcontrib>Shimamoto, Hiroaki</creatorcontrib><creatorcontrib>Matsumura, Kouji</creatorcontrib><creatorcontrib>Arvind, Ramanathan</creatorcontrib><creatorcontrib>Zhang, Shengliang</creatorcontrib><creatorcontrib>Sakai, Eiki</creatorcontrib><creatorcontrib>Omura, Ken</creatorcontrib><creatorcontrib>Tsuchida, Nobuo</creatorcontrib><creatorcontrib>Tokyo Medical and Dental University</creatorcontrib><creatorcontrib>Laboratory of Cell Analysis</creatorcontrib><creatorcontrib>Central Research Institute</creatorcontrib><creatorcontrib>Department of Molecular Cellular Oncology and Microbiology</creatorcontrib><creatorcontrib>Oral and Maxillofacial Surgery</creatorcontrib><creatorcontrib>Dokkyo University School of Medicine</creatorcontrib><creatorcontrib>National Defense Medical College</creatorcontrib><creatorcontrib>Department of Oral and Maxillofacial Surgery</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Medical and Dental Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kaneda, Yoshimasa</au><au>Shimamoto, Hiroaki</au><au>Matsumura, Kouji</au><au>Arvind, Ramanathan</au><au>Zhang, Shengliang</au><au>Sakai, Eiki</au><au>Omura, Ken</au><au>Tsuchida, Nobuo</au><aucorp>Tokyo Medical and Dental University</aucorp><aucorp>Laboratory of Cell Analysis</aucorp><aucorp>Central Research Institute</aucorp><aucorp>Department of Molecular Cellular Oncology and Microbiology</aucorp><aucorp>Oral and Maxillofacial Surgery</aucorp><aucorp>Dokkyo University School of Medicine</aucorp><aucorp>National Defense Medical College</aucorp><aucorp>Department of Oral and Maxillofacial Surgery</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of caspase 8 as a determinant in chemosensitivity of p53-mutated head and neck squamous cell carcinoma cell lines</atitle><jtitle>Journal of Medical and Dental Sciences</jtitle><addtitle>J. med. dent. sci.</addtitle><date>2006-03</date><risdate>2006</risdate><volume>53</volume><issue>1</issue><spage>57</spage><epage>66</epage><pages>57-66</pages><issn>1342-8810</issn><eissn>2185-9132</eissn><abstract>We studied factors that control chemoresistanceto 6 head and neck squamous cell carcinomacell lines carrying p53 mutations. Cell lines werechosen, based on the presence of EGFR amplifications,the presence of H-ras mutations, and theabsence of either. WST-1 viability assays showedthat, in response to etoposide, Ca922 was mostsensitive, HOC313 most resistant, and HSC6 andthe others moderately sensitive. A similar tendencywas shown by further analyses with cisplatin, 5-fluorouracil,LY294002, and combined treatment withLY294002 and TNF-related apoptosis-inducing ligand(TRAIL). Although both Ca922 and HOC313 hadactivating mutations upstream of Akt signaling, theconstitutive phosphorylation of Akt at S473 wasobserved in chemosensitive Ca922, but not inchemoresistant HOC313, suggesting that constitutiveAkt phosphorylation was not the primarydeterminant for chemoresistance in these celllines. Further, by the combined treatment withLY294002 and TRAIL, apoptosis was induced inCa922 and HSC6 but not in HOC313. Interestingly,caspase 8 was not detected in HOC313, while itwas cleaved in the other 2 cell lines. Further, inCa922 and HSC6 but not in HOC313, caspase 8inhibitor restored loss of viability induced eitherwith LY294002 and TRAIL or even with etoposidealone. These findings suggest that caspase 8played an important role in chemoresistanceagainst genotoxic drugs.</abstract><cop>Japan</cop><pub>Tokyo Medical and Dental University (TMDU)</pub><pmid>16722146</pmid><doi>10.11480/jmds.530108</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1342-8810 |
ispartof | Journal of Medical and Dental Sciences, 2006, Vol.53(1), pp.57-66 |
issn | 1342-8810 2185-9132 |
language | eng |
recordid | cdi_proquest_miscellaneous_68005396 |
source | J-STAGE Free; MEDLINE; Freely Accessible Japanese Titles; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Akt Antineoplastic Agents - pharmacology Apoptosis - drug effects Apoptosis Regulatory Proteins - pharmacology Carcinoma, Squamous Cell - enzymology Carcinoma, Squamous Cell - genetics Caspase 8 Caspases - physiology Cell Line, Tumor - drug effects Cell Line, Tumor - enzymology Chromones - pharmacology Cisplatin - pharmacology Dentistry Drug Resistance, Neoplasm - genetics Drug Resistance, Neoplasm - physiology etoposide Etoposide - pharmacology Fluorouracil - pharmacology Head and Neck Neoplasms - enzymology Head and Neck Neoplasms - genetics head and neck squamous cell carcinoma Humans Membrane Glycoproteins - pharmacology Morpholines - pharmacology Mutation Phosphorylation Proto-Oncogene Proteins c-akt - metabolism TNF-Related Apoptosis-Inducing Ligand TRAIL Tumor Necrosis Factor-alpha - pharmacology Tumor Suppressor Protein p53 - genetics |
title | Role of caspase 8 as a determinant in chemosensitivity of p53-mutated head and neck squamous cell carcinoma cell lines |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T01%3A50%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20caspase%208%20as%20a%20determinant%20in%20chemosensitivity%20of%20p53-mutated%20head%20and%20neck%20squamous%20cell%20carcinoma%20cell%20lines&rft.jtitle=Journal%20of%20Medical%20and%20Dental%20Sciences&rft.au=Kaneda,%20Yoshimasa&rft.aucorp=Tokyo%20Medical%20and%20Dental%20University&rft.date=2006-03&rft.volume=53&rft.issue=1&rft.spage=57&rft.epage=66&rft.pages=57-66&rft.issn=1342-8810&rft.eissn=2185-9132&rft_id=info:doi/10.11480/jmds.530108&rft_dat=%3Cproquest_pubme%3E68005396%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68005396&rft_id=info:pmid/16722146&rfr_iscdi=true |